TN2010000011A1 - Improved pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof - Google Patents

Improved pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Info

Publication number: TN2010000011A1
Authority: TN; Tunisia
Prior art keywords: preparation; calcium channel; channel antagonist; pharmaceutical composition; composition containing
Prior art date: 2007-07-23

Application number

TNP2010000011A

Other languages

English (en)

Inventor

Evangelos Karavas

Makis Koutris

Vicky Samara

Christina Matsingou

Athina Iliopoulou

Original Assignee

Pharmathen Sa

Recordati Ireland Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-23

Filing date

2010-01-08

Publication date

2011-09-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39223083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2010000011(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-01-08 Application filed by Pharmathen Sa, Recordati Ireland Ltd filed Critical Pharmathen Sa

2011-09-26 Publication of TN2010000011A1 publication Critical patent/TN2010000011A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Vascular Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Inorganic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Hydrogenated Pyridines (AREA)

TNP2010000011A 2007-07-23 2010-01-08 Improved pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof TN2010000011A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/EP2007/006517 WO2009012791A1 (fr)	2007-07-23	2007-07-23	Composition pharmaceutique contenant un antagoniste des canaux calciques de type dihydropyridine et son procédé de préparation
PCT/EP2008/059645 WO2009013306A1 (fr)	2007-07-23	2008-07-23	Composition pharmaceutique améliorée contenant un antagoniste de canal calcique de dihydropyridine et son procédé de préparation

Publications (1)

Publication Number	Publication Date
TN2010000011A1 true TN2010000011A1 (en)	2011-09-26

Family

ID=39223083

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
TNP2010000011A TN2010000011A1 (en)	2007-07-23	2010-01-08	Improved pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
TNP2010000022A TN2010000022A1 (en)	2007-07-23	2010-01-13	Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
TNP2010000022A TN2010000022A1 (en)	2007-07-23	2010-01-13	Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Country Status (20)

Country	Link
EP (2)	EP2180883B1 (fr)
JP (2)	JP5769963B2 (fr)
KR (2)	KR101632079B1 (fr)
CN (3)	CN101784260A (fr)
AU (2)	AU2007356942B2 (fr)
BR (2)	BRPI0721883A2 (fr)
CA (2)	CA2691752C (fr)
CO (1)	CO6290639A2 (fr)
CR (1)	CR11285A (fr)
EA (2)	EA021645B1 (fr)
EC (1)	ECSP109984A (fr)
ES (2)	ES2622495T3 (fr)
MA (1)	MA31684B1 (fr)
MX (2)	MX2010000856A (fr)
MY (1)	MY153857A (fr)
NZ (2)	NZ582648A (fr)
TN (2)	TN2010000011A1 (fr)
UA (2)	UA97161C2 (fr)
WO (2)	WO2009012791A1 (fr)
ZA (2)	ZA201000586B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2008063888A2 (fr)	2006-11-22	2008-05-29	Plexxikon, Inc.	Composés modulant l'activité de c-fms et/ou de c-kit et utilisations associées
MX2010000617A (es)	2007-07-17	2010-05-17	Plexxikon Inc	Compuestos y metodos para modulacion de cinasa, e indicaciones de estos.
UA97161C2 (ru) *	2007-07-23	2012-01-10	Фарматен С.А.	Фармацевтическая композиция, которая содержит дигидропиридиновый антагонист кальциевого канала лерканидипин и коллоидный диоксид кремния, способ ее приготовления
AU2010232670B2 (en)	2009-04-03	2015-07-09	F. Hoffmann-La Roche Ag	Propane- I-sulfonic acid {3- [5- (4 -chloro-phenyl) -1H-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof
US8329724B2 (en)	2009-08-03	2012-12-11	Hoffmann-La Roche Inc.	Process for the manufacture of pharmaceutically active compounds
MA33975B1 (fr)	2009-11-06	2013-02-01	Plexxikon Inc	Composés et méthodes de modulation des kinases et leurs indications d'emploi
HUE040136T2 (hu)	2011-02-07	2019-02-28	Plexxikon Inc	Vegyületek és eljárások kináz modulációra és azok indikációi
TWI558702B (zh)	2011-02-21	2016-11-21	普雷辛肯公司	醫藥活性物質的固態形式
US9150570B2 (en)	2012-05-31	2015-10-06	Plexxikon Inc.	Synthesis of heterocyclic compounds
JP2015537029A (ja)	2012-11-14	2015-12-24	ダブリュー・アール・グレース・アンド・カンパニー−コーンＷＲＧｒａｃｅ＆Ｃｏ−Ｃｏｎｎ	生物学的に活性な物質及び不規則性無機酸化物を含有する組成物
GR1008554B (el) *	2014-06-12	2015-09-03	ΦΑΡΜΑΤΕΝ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΙΑΤΡΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ με δ.τ. ΦΑΡΜΑΤΕΝ,	Φαρμακευτικο σκευασμα περιεχον εναν αντιμυκητιασικο παραγοντα τριaζολης και μεθοδος για την παρασκευη αυτου
CN104069500A (zh) *	2014-06-20	2014-10-01	湖南天地恒一制药有限公司	一种包含乐卡地平的药物组合物
CN105168165B (zh) *	2015-08-28	2018-06-26	江苏福邦药业有限公司	一种盐酸乐卡地平片及其制备方法
WO2018004379A1 (fr) *	2016-07-01	2018-01-04	Общество С Ограниченной Ответственностью "Гиостин"	Produit sous forme de capsule pour traiter des maladies d'articulations
AU2019225236B2 (en)	2018-02-26	2025-01-30	R.P. Scherer Technologies, Llc	Pharmaceutical dosage form for an emulsion of simethicone and loperamide
EA202092186A1 (ru)	2018-03-22	2020-12-16	Комифарм Интернэшнл Австралия Пти Лтд	Фармацевтическая композиция, содержащая метаарсенит, и способ изготовления
CN114533686B (zh) *	2022-02-15	2023-10-20	湖南普道医药技术有限公司	一种二氢吡啶类药物的口服固体制剂及其制备方法
KR20240040407A (ko) *	2022-09-21	2024-03-28	주식회사 종근당	사쿠비트릴ㆍ발사르탄 칼슘염을 포함하는 약제학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3720757A1 (de) *	1987-06-24	1989-01-05	Bayer Ag	Dhp-manteltablette
US5209933A (en) *	1990-01-10	1993-05-11	Syntex (U.S.A.) Inc.	Long acting calcium channel blocker composition
GB9025251D0 (en) *	1990-11-20	1991-01-02	Solomon Montague C	Nifedipine dosage forms
BR9903490A (pt) *	1998-12-15	2000-09-26	Oscar Gold	Processo para a preparação de composições farmacêuticas de liberação programada contendo nimodipine, que permitem a liberação gradual e a manuntenção da ação terapeutica
DE19944803A1 (de) *	1999-09-20	2001-03-29	Bayer Ag	Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
US20040185097A1 (en) *	2003-01-31	2004-09-23	Glenmark Pharmaceuticals Ltd.	Controlled release modifying complex and pharmaceutical compositions thereof
WO2005053689A2 (fr) *	2003-12-01	2005-06-16	Lifecycle Pharma A/S	Compositions pharmaceutiques comprenant de la lercanidipine
CN1901888A (zh) *	2003-12-01	2007-01-24	生命周斯药物公司	包含乐卡地平的药物组合物
EP2063872B2 (fr) *	2006-08-30	2019-12-04	Jagotec AG	Formulations posologiques à libération contrôlée administrées par voie orale comprenant un noyau et une ou plusieurs couches barrières
EP2101771A2 (fr) *	2006-12-06	2009-09-23	Torrent Pharmaceuticals Ltd	Formulation stable de lercanidipine
UA97161C2 (ru) *	2007-07-23	2012-01-10	Фарматен С.А.	Фармацевтическая композиция, которая содержит дигидропиридиновый антагонист кальциевого канала лерканидипин и коллоидный диоксид кремния, способ ее приготовления

2007
- 2007-07-23 UA UAA201001781A patent/UA97161C2/ru unknown
- 2007-07-23 JP JP2010517273A patent/JP5769963B2/ja not_active Expired - Fee Related
- 2007-07-23 NZ NZ582648A patent/NZ582648A/en unknown
- 2007-07-23 AU AU2007356942A patent/AU2007356942B2/en active Active
- 2007-07-23 BR BRPI0721883-4A2A patent/BRPI0721883A2/pt not_active IP Right Cessation
- 2007-07-23 MX MX2010000856A patent/MX2010000856A/es active IP Right Grant
- 2007-07-23 CN CN200780100025A patent/CN101784260A/zh active Pending
- 2007-07-23 KR KR1020107001425A patent/KR101632079B1/ko active Active
- 2007-07-23 ES ES07786262.1T patent/ES2622495T3/es active Active
- 2007-07-23 EA EA201070160A patent/EA021645B1/ru not_active IP Right Cessation
- 2007-07-23 CA CA2691752A patent/CA2691752C/fr active Active
- 2007-07-23 WO PCT/EP2007/006517 patent/WO2009012791A1/fr not_active Ceased
- 2007-07-23 EP EP07786262.1A patent/EP2180883B1/fr active Active
2008
- 2008-07-23 MY MYPI2010000318A patent/MY153857A/en unknown
- 2008-07-23 BR BRPI0814666A patent/BRPI0814666A2/pt not_active IP Right Cessation
- 2008-07-23 WO PCT/EP2008/059645 patent/WO2009013306A1/fr not_active Ceased
- 2008-07-23 CA CA2693233A patent/CA2693233A1/fr not_active Abandoned
- 2008-07-23 AU AU2008280106A patent/AU2008280106B9/en not_active Ceased
- 2008-07-23 EP EP20080775312 patent/EP2170295B1/fr active Active
- 2008-07-23 CN CN201410243247.6A patent/CN103976968A/zh active Pending
- 2008-07-23 ES ES08775312.5T patent/ES2537063T3/es active Active
- 2008-07-23 UA UAA201000447A patent/UA99136C2/ru unknown
- 2008-07-23 MX MX2010000801A patent/MX2010000801A/es active IP Right Grant
- 2008-07-23 CN CN200880100075A patent/CN101801347A/zh active Pending
- 2008-07-23 KR KR1020107002430A patent/KR101512404B1/ko not_active Expired - Fee Related
- 2008-07-23 JP JP2010517393A patent/JP2010534220A/ja active Pending
- 2008-07-23 NZ NZ582690A patent/NZ582690A/en not_active IP Right Cessation
- 2008-07-23 EA EA201000220A patent/EA019614B1/ru unknown
2010
- 2010-01-08 TN TNP2010000011A patent/TN2010000011A1/fr unknown
- 2010-01-13 TN TNP2010000022A patent/TN2010000022A1/fr unknown
- 2010-01-20 CO CO10005281A patent/CO6290639A2/es not_active Application Discontinuation
- 2010-01-26 ZA ZA2010/00586A patent/ZA201000586B/en unknown
- 2010-02-17 MA MA32628A patent/MA31684B1/fr unknown
- 2010-02-18 ZA ZA2010/01176A patent/ZA201001176B/en unknown
- 2010-02-19 CR CR11285A patent/CR11285A/es unknown
- 2010-02-23 EC EC2010009984A patent/ECSP109984A/es unknown

Also Published As

Publication number	Publication date
KR20100047848A (ko)	2010-05-10
CA2691752A1 (fr)	2009-01-29
AU2008280106B2 (en)	2014-03-20
ES2622495T3 (es)	2017-07-06
EA019614B1 (ru)	2014-05-30
NZ582690A (en)	2011-12-22
WO2009012791A1 (fr)	2009-01-29
AU2008280106A1 (en)	2009-01-29
NZ582648A (en)	2012-06-29
JP5769963B2 (ja)	2015-08-26
MX2010000801A (es)	2010-07-05
CN103976968A (zh)	2014-08-13
TN2010000022A1 (en)	2011-09-26
EA201000220A1 (ru)	2010-08-30
BRPI0721883A2 (pt)	2014-02-18
UA97161C2 (ru)	2012-01-10
EP2170295A1 (fr)	2010-04-07
JP2010534211A (ja)	2010-11-04
KR101512404B1 (ko)	2015-04-21
UA99136C2 (ru)	2012-07-25
KR101632079B1 (ko)	2016-06-20
CA2693233A1 (fr)	2009-01-29
AU2007356942B2 (en)	2011-12-15
CA2691752C (fr)	2016-01-26
MA31684B1 (fr)	2010-09-01
MY153857A (en)	2015-03-31
EP2180883A1 (fr)	2010-05-05
EA201070160A1 (ru)	2010-06-30
CR11285A (es)	2010-04-27
AU2008280106B9 (en)	2014-08-07
AU2007356942A1 (en)	2009-01-29
CN101801347A (zh)	2010-08-11
BRPI0814666A2 (pt)	2017-05-09
MX2010000856A (es)	2010-04-30
ECSP109984A (es)	2010-04-30
ES2537063T3 (es)	2015-06-02
JP2010534220A (ja)	2010-11-04
ZA201000586B (en)	2011-03-30
CN101784260A (zh)	2010-07-21
EP2180883B1 (fr)	2017-01-11
EP2170295B1 (fr)	2015-04-22
KR20100045456A (ko)	2010-05-03
EA021645B1 (ru)	2015-08-31
CO6290639A2 (es)	2011-06-20
WO2009013306A1 (fr)	2009-01-29
AU2008280106A2 (en)	2010-02-25
ZA201001176B (en)	2010-11-24

Publication	Publication Date	Title
TN2010000011A1 (en)	2011-09-26	Improved pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
WO2010065709A3 (fr)	2010-10-07	Dérivés d'acide hydroxamique, préparation et utilisations thérapeutiques de ceux-ci
MY149731A (en)	2013-10-14	Compounds
JO2973B1 (en)	2016-03-15	Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
EA201170753A1 (ru)	2011-12-30	Налмефена гидрохлорид дигидрат
WO2014016754A3 (fr)	2014-03-13	Compositions pharmaceutiques d'inhibiteur de la pompe à protons
WO2010049449A3 (fr)	2010-11-25	Nouveaux sels de sunitinib
ZA201003380B (en)	2011-12-28	Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and methhod for the preparation thereof
WO2008001201A3 (fr)	2009-04-23	Compositions pharmaceutiques de clopidogrel
WO2010070677A3 (fr)	2011-02-24	Procédé de préparation de prasugrel et de ses sels pharmaceutiquement acceptables
NZ591204A (en)	2013-02-22	Pharmaceutical compositions and methods for stabilizing the same
EA200900463A1 (ru)	2009-06-30	Арипипразола гемифумарат и способ его получения
WO2010044097A3 (fr)	2010-11-04	Nouvelle forme pharmaceutique de palipéridone et procédé de préparation de celle-ci
WO2007110765A3 (fr)	2009-04-16	Procedes de preparation d'octreotide
GR1008821B (el)	2016-08-01	Φαρμακευτικο σκευασμα που περιλαμβανει υδροχλωρικη ιβαμπραδινη και μεθοδος παρασκευης αυτου
WO2010061220A3 (fr)	2010-08-19	Nouveaux procédés et polymorphes purs
GR20070100405A (el)	2009-01-20	Βελτιωμενες φαρμακοτεχνικες μορφες που περιεχουν αναστολεις της ακετυλοχοληνεστερασης και μεθοδοι παρασκευης αυτων
MY150480A (en)	2014-01-30	Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
CY1108846T1 (el)	2014-07-02	Βελτιωμενη φαρμακευτικη συνθεση που περιεχει αναστολεα ace και μεθοδος για την παρασκευη της
WO2011086577A3 (fr)	2011-09-09	Composition pharmaceutique de moxifloxacine et ses sels pharmaceutiquement acceptables
WO2010061219A3 (fr)	2010-08-12	Formes polymorphiques
WO2010046912A3 (fr)	2010-07-01	Analogues de fluconazole contenant du tiophène utilisés en tant qu'agents et procédé d'utilisation associé
CO6260055A2 (es)	2011-03-22	Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihidropiridina y metodo para la preparacion de la misma
GR1007741B (el)	2012-10-29	Φαρμακευτικο σκευασμα περιεχον εναν ατυπικο αντιψυχωτικο παραγοντα και μεθοδος για την παρασκευη αυτου
GR1008082B (el)	2014-01-17	Φαρμακευτικο σκευασμα περιεχον εναν ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου